JP2023523719A5 - - Google Patents

Info

Publication number
JP2023523719A5
JP2023523719A5 JP2022563981A JP2022563981A JP2023523719A5 JP 2023523719 A5 JP2023523719 A5 JP 2023523719A5 JP 2022563981 A JP2022563981 A JP 2022563981A JP 2022563981 A JP2022563981 A JP 2022563981A JP 2023523719 A5 JP2023523719 A5 JP 2023523719A5
Authority
JP
Japan
Prior art keywords
complex
agent
epidermolysis bullosa
complex according
decorin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022563981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023523719A (ja
JP7824885B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2021/050318 external-priority patent/WO2021219940A1/en
Publication of JP2023523719A publication Critical patent/JP2023523719A/ja
Publication of JP2023523719A5 publication Critical patent/JP2023523719A5/ja
Application granted granted Critical
Publication of JP7824885B2 publication Critical patent/JP7824885B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022563981A 2020-04-28 2021-04-28 表皮水疱症の治療で使用するためのホーミングペプチド誘導デコリン複合体 Active JP7824885B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063016359P 2020-04-28 2020-04-28
FI20205431 2020-04-28
US63/016,359 2020-04-28
FI20205431 2020-04-28
PCT/FI2021/050318 WO2021219940A1 (en) 2020-04-28 2021-04-28 Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa

Publications (3)

Publication Number Publication Date
JP2023523719A JP2023523719A (ja) 2023-06-07
JP2023523719A5 true JP2023523719A5 (cg-RX-API-DMAC7.html) 2024-05-07
JP7824885B2 JP7824885B2 (ja) 2026-03-05

Family

ID=75870661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563981A Active JP7824885B2 (ja) 2020-04-28 2021-04-28 表皮水疱症の治療で使用するためのホーミングペプチド誘導デコリン複合体

Country Status (10)

Country Link
US (1) US20230167162A1 (cg-RX-API-DMAC7.html)
EP (1) EP4142771A1 (cg-RX-API-DMAC7.html)
JP (1) JP7824885B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230005314A (cg-RX-API-DMAC7.html)
CN (1) CN115605218B (cg-RX-API-DMAC7.html)
AU (1) AU2021266157A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022021879A2 (cg-RX-API-DMAC7.html)
CA (1) CA3180694A1 (cg-RX-API-DMAC7.html)
IL (1) IL297703A (cg-RX-API-DMAC7.html)
WO (1) WO2021219940A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118001404B (zh) * 2024-02-06 2025-02-25 四川大学华西医院 抑制C17orf67基因表达试剂在制备治疗获得性大疱表皮松解症药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136869A2 (en) 2006-12-06 2008-11-13 Burnham Institute For Medical Research Methods and compositions related to targeting wounds, regenerating tissue, and tumors

Similar Documents

Publication Publication Date Title
CA2387184C (en) Cell-permeable peptide inhibitors of the jnk signal transduction pathway
JP2024102211A5 (cg-RX-API-DMAC7.html)
JP2023544834A5 (cg-RX-API-DMAC7.html)
IL321500A (en) Pre-stabilized hmpv f proteins
JP2012505902A5 (cg-RX-API-DMAC7.html)
US20220111003A1 (en) Neuroprotective peptides
ES2985967T3 (es) Métodos y composiciones para el tratamiento del cáncer
JP2014508510A5 (cg-RX-API-DMAC7.html)
Dietz Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research
US12208131B2 (en) ATF5 peptide variants and uses thereof
JP2018522563A5 (cg-RX-API-DMAC7.html)
JP2010534486A5 (cg-RX-API-DMAC7.html)
JP2023528207A5 (cg-RX-API-DMAC7.html)
CA2648109A1 (en) Combination of an anti-ed-b fibronectin domain antibody-il-2 fusion protein and gemcitabine
JP2018538356A5 (cg-RX-API-DMAC7.html)
JP2023116739A5 (cg-RX-API-DMAC7.html)
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
JP2010536714A5 (cg-RX-API-DMAC7.html)
FI4034555T3 (fi) Dap10/dap12-fuusiopolypeptidit
JP2026035742A5 (cg-RX-API-DMAC7.html)
JP2023523719A5 (cg-RX-API-DMAC7.html)
JP2023542453A5 (cg-RX-API-DMAC7.html)
JP2023509004A5 (cg-RX-API-DMAC7.html)
AU2005307160B2 (en) Novel antimicrobial peptides
AU2020311873B2 (en) Modified BCL9 mimetic peptides